J1170 — Injection, hydromorphone, up to 4 mg
J1170 is a HCPCS Level II code for injection, hydromorphone, up to 4 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on September 30, 2024 and is not valid on new claims.
This code has been terminated
CMS terminated J1170 on September 30, 2024. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J1170
- Long descriptor
- Injection, hydromorphone, up to 4 mg
- Short descriptor
- Hydromorphone injection
- Added
- January 1, 1982
- Terminated
- September 30, 2024
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J1170
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1170 is not quite right, the correct code is very often within a few positions of it.
- J1110Injection, dihydroergotamine mesylate, per 1 mg
- J1120Injection, acetazolamide sodium, up to 500 mg
- J1130Injection, diclofenac sodium, 0.5 mg
- J1160Injection, digoxin, up to 0.5 mg
- J1162Injection, digoxin immune fab (ovine), per vial
- J1163Injection, diltiazem hydrochloride, 0.5 mg
- J1164Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
- J1165Injection, phenytoin sodium, per 50 mg
- J1171Injection, hydromorphone, 0.1 mg
- J1180Injection, dyphylline, up to 500 mg
- J1190Injection, dexrazoxane hydrochloride, per 250 mg
- J1200Injection, diphenhydramine hcl, up to 50 mg
- J1201Injection, cetirizine hydrochloride, 0.5 mg
- J1202Miglustat, oral, 65 mg
- J1203Injection, cipaglucosidase alfa-atga, 5 mg
- J1205Injection, chlorothiazide sodium, per 500 mg
Questions about J1170
What is HCPCS code J1170?
J1170 is a HCPCS Level II code for injection, hydromorphone, up to 4 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J1170?
The CMS HCPCS file marks J1170 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J1170 still valid?
No. J1170 was terminated on September 30, 2024 and should not be used on new claims.